A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

NCT06926582 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: HS-10374 6mg tablets
DRUG: HS-10374-matched placebo tablets

Sponsor

Hansoh BioMedical R&D Company